aifollow.news
Back IT之家 科技新闻
IT之家 科技新闻· · Original publication time SelectedAI score60

Google presents cuff-free hypertension screening research using consumer smartwatchesMachine translation

谷歌发布智能手表无袖带筛查高血压研究

AI-assisted summary

Google introduced AI-PPG-ACC-HTN, which uses physiological features collected over multiple days by consumer smartwatches to identify signs of persistent hypertension without cuff calibration. In a multicenter clinical trial of 196 participants, initial screening achieved 65.8% sensitivity and 90.0% specificity against 24-hour ambulatory blood pressure monitoring; the screening result is not a diagnosis.

Article · AI translation

IT Home reported on November 7 that Google published a blog post on November 5 local time introducing its latest research findings published in Nature.

Google introduced a multimodal AI system called AI-PPG-ACC-HTN. Without cuff calibration, the system can passively detect signs of hypertension using an ordinary consumer smartwatch.

According to Google, conventional approaches try to estimate individual, momentary systolic and diastolic blood pressure readings, which are highly susceptible to transient environmental noise. The new system takes a different approach: by aggregating passive physiological features collected continuously over multiple days, it focuses on identifying an individual's underlying, persistent hypertension.

Self-supervised pretraining: A 1D-CNN was trained on more than 490,000 hours of unlabeled data, using contrastive learning to enable the model to discover complex cardiovascular physiological features on its own.

Multi-day aggregation and classification: Feature vectors from 15-second intervals over multiple days are averaged to smooth transient noise and combined with height, which represents arterial path length. A logistic regression model then outputs a probability score for persistent hypertension.

To assess its performance, the research team conducted a prospective, multicenter clinical trial at 5 clinical centers across the United States. The trial enrolled 196 participants with no history of cardiovascular disease who were not taking blood pressure medication, and used the clinical gold standard, 24-hour ambulatory blood pressure monitoring, as its reference. The results showed:

Initial screening: Specificity was 90.0%, positive predictive value (PPV) was 80.6%, and sensitivity was 65.8% (better than the 55.3% sensitivity and 77.8% PPV of a single initial in-office screening).

Confirmatory testing (for people whose initial screening results were elevated): PPV reached 96.7%, specificity reached 90.9%, and sensitivity reached 78.4%, outperforming repeat in-office measurements and comparable to continuous home cuff monitoring that requires several days of wear.

IT Home has learned that these research findings have provided core technical support for the blood pressure trends “Health Guardian” feature in Google's health app.

Found an error? Send a correction